SOURCE: Masimo

Masimo

Masimo

September 29, 2014 08:01 ET

Mercy Hospital of Buffalo Expands Use of Masimo Patient SafetyNet™ After Pilot Program Shows Reduction in Mortality

BUFFALO NY and IRVINE, CA--(Marketwired - Sep 29, 2014) - Masimo (NASDAQ: MASI) and Mercy Hospital of Buffalo -- one of the largest hospitals in Western New York -- today announced the facility has expanded continuous patient monitoring using Masimo SET® pulse oximetry and the Masimo Patient SafetyNet™ remote monitoring and clinician notification system after seeing reduction in mortality on a pilot-program floor.

At Mercy, Masimo Radical-7 and Rad-87 devices continuously monitor oxygenation with Masimo SET® pulse oximetry and breathing with RRa. Patient Safety net enables the remote monitoring and wireless notification to clinicians of events detected by the bedside devices.

"After conducting a 30-month study of Patient SafetyNet on the hospital's 33-bed medical/surgical 6 McAuley West Unit, the hospital concluded that continuous patient monitoring can benefit all patients and potentially save lives, and so expanded the system throughout the hospital," said Jon Carlson, Mercy Hospital's Director of Respiratory Care.

"The outcome of the trial was a reduction in all-cause mortality on the pilot floor (excluding hospice and comfort care patients from both baseline and study data)," said Carlson. "The Patient SafetyNet monitoring system gives us the opportunity to further enhance patient safety, improve outcomes, and reduce costs by avoiding preventable patient transfers to the ICU."

Carlson noted that a key feature of the Patient SafetyNet system is Masimo SET with ability to measure through challenging patient conditions, including motion as well as low perfusion (or diminished blood flow).

Kathleen Guarino, Mercy Hospital's Vice President of Nursing and Chief Nursing Officer, said Patient SafetyNet is also helping the staff better manage patients' pain. "It provides a 'safety net' by constantly monitoring oxygen saturation and breathing, which is especially important for our patients using narcotic pain medication," she said.

"We are honored and humbled that our technology has helped Mercy Hospital achieve better patient outcomes," said Joe Kiani founder and CEO of Masimo. "We hope all hospitals one day will implement our technology for continuous monitoring of patients, which has been shown to save lives and reduce costs."

About Mercy Hospital of Buffalo
Mercy Hospital of Buffalo, part of Catholic Health, is one of the largest and busiest hospitals in Western New York. As home to the Catholic Health Heart Center, the hospital offers a full range of cardiac care services including heart surgery, cardiac catheterization and minimally-invasive cardiology procedures. A recognized leader in advanced stroke care, Mercy Hospital is the only local hospital to earn Comprehensive Stroke Center designation by The Joint Commission, the nation's leading accrediting body for hospitals and health providers. Mercy's Family Birthplace provides a full spectrum of maternity/child and neonatal intensive care services, as well as a specialized pediatric care unit. For more information, visit the Catholic Health website at www.chsbuffalo.org.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.

Forward Looking Statements
 
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that all patients at Mercy Hospital of Buffalo will be cared for using the most technologically and clinically-advanced noninvasive patient monitoring solutions available; risks related to our belief that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events; risks related to our belief that Masimo SET virtually eliminates false alarms and increases a clinician's ability to detect life-threatening events; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo Corporation

Contact Information